Repaglinide versus sulfonylurea in combination with bedtime NPH insulin in patients with type 2 diabetes with secondary failure to oral treatment

被引:0
|
作者
Strojek, K
Polaszewska-Muszynska, M
Krassowski, J
Gumprecht, J
Rudzki, H
Olejniczak, H
Nazar, M
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A135 / A135
页数:1
相关论文
共 50 条
  • [1] Repaglinide versus sulphonylurea in combination with bedtime NPH insulin in patients with Type 2 diabetes with secondary failure to oral treatment.
    Strojek, K
    Polaszewska-Muszynska, M
    Krassowski, J
    Gumprecht, J
    Rudzki, H
    Olejniczak, H
    Nazar, M
    [J]. DIABETOLOGIA, 2003, 46 : A282 - A282
  • [2] Repaglinide versus meiformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy
    Furlong, MJ
    Hulme, SA
    O'Brien, SV
    Hardy, KJ
    [J]. DIABETES CARE, 2002, 25 (10) : 1685 - 1690
  • [3] Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes
    Civera, Miguel
    Merchante, Angel
    Salvador, Maria
    Sanz, Javier
    Martinez, Isidoro
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (01) : 42 - 47
  • [4] Insulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failure
    RavnikOblak, M
    Mrevlje, F
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 30 (01) : 27 - 35
  • [5] Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents
    Furlong, NJ
    Hulme, SA
    O'Brien, SV
    Hardy, KJ
    [J]. DIABETIC MEDICINE, 2003, 20 (11) : 935 - 941
  • [6] TRIAL OF COMBINATION INSULIN SULFONYLUREA THERAPY FOR TYPE-II DIABETES - BEDTIME NPH INSULIN MORNING GLYBURIDE VERSUS INSULIN ALONE
    RIDDLE, M
    HART, J
    BOUMA, D
    PHILLIPSON, B
    YOUKER, J
    [J]. CLINICAL RESEARCH, 1986, 34 (01): : A64 - A64
  • [7] Combination of insulin lispro (LP), metformin (MF), or bedtime NPH (NPH) with sulfonylurea (SU) following secondary SU failure
    Browdos, R
    Schwartz, S
    Stuart, CA
    Zagar, A
    Graf, CJ
    Bastyr, EJ
    [J]. DIABETES, 1999, 48 : A104 - A104
  • [8] THE COMBINATION OF INSULIN AND SULFONYLUREA IN THE TREATMENT OF SECONDARY DRUG FAILURE IN PATIENTS WITH TYPE-II DIABETES
    GROOP, L
    HARNO, K
    TOLPPANEN, EM
    [J]. ACTA ENDOCRINOLOGICA, 1984, 106 (01): : 97 - 101
  • [9] COMPARISON OF BEDTIME NPH OR PREPRANDIAL REGULAR INSULIN COMBINED WITH GLIBENCLAMIDE IN SECONDARY SULFONYLUREA FAILURE
    LANDSTEDTHALLIN, L
    ADAMSON, U
    ARNER, P
    BOLINDER, J
    LINS, PE
    [J]. DIABETES CARE, 1995, 18 (08) : 1183 - 1186
  • [10] Comparison of repaglinide versus gliclazide combined with nocturnal NPH insulin in patients with type 2 diabetes
    Furlong, NJ
    Hulme, SA
    O Brien, SV
    Hardy, KJ
    [J]. DIABETES, 2002, 51 : A97 - A97